Literature DB >> 3572033

Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983.

W P Glezen, M Decker, S W Joseph, R G Mercready.   

Abstract

Virological surveillance at "sentinel" clinics in Houston has demonstrated that the annual peak in the number of visits for acute respiratory disease (ARD) always coincides with the peak of influenza virus activity. A survey of visits to a health maintenance organization between 1981 and 1983 allowed us to calculate the age-specific rates of visits for ARD during two moderately severe influenza epidemics (1981-1982 and 1982-1983). During the most intense period of influenza virus activity the rate of visits for ARD was about 12 per 100 persons; the risk of developing ARD was greatest for preschool children (1981-1982, 27 per 100; 1982-1983, 29 per 100) and averaged about 10 per 100 for persons greater than 10 years of age. The risk of hospitalization with ARD was about 10 per 10,000 persons for residents of Harris County (Texas) during the same epidemics and was greatest for persons greater than 65 years of age.

Entities:  

Mesh:

Year:  1987        PMID: 3572033     DOI: 10.1093/infdis/155.6.1119

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts.

Authors:  Terho Heikkinen; Robert Booy; Magda Campins; Adam Finn; Per Olcén; Heikki Peltola; Carlos Rodrigo; Heinz-Josef Schmitt; Fabian Schumacher; Stephen Teo; Catherine Weil-Olivier
Journal:  Eur J Pediatr       Date:  2005-12-21       Impact factor: 3.183

Review 2.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 3.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

4.  A Bayesian dynamic model for influenza surveillance.

Authors:  Paola Sebastiani; Kenneth D Mandl; Peter Szolovits; Isaac S Kohane; Marco F Ramoni
Journal:  Stat Med       Date:  2006-06-15       Impact factor: 2.373

5.  Influenza surveillance in an urban area.

Authors:  W P Glezen
Journal:  Can J Infect Dis       Date:  1993-09

6.  Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Authors:  Pedro A Piedra; Manjusha J Gaglani; Mark Riggs; Gayla Herschler; Charles Fewlass; Matt Watts; Claudia Kozinetz; Colin Hessel; W Paul Glezen
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

Review 7.  Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?

Authors:  Paul V Targonski; Gregory A Poland
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

8.  Influenza as a proportion of pneumonia mortality: United States, 1959-2009.

Authors:  Andrew Noymer; Ann M Nguyen
Journal:  Biodemography Soc Biol       Date:  2013

9.  CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly.

Authors:  Laura Haynes; Sheri M Eaton; Eve M Burns; Troy D Randall; Susan L Swain
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

Review 10.  The economic impact of pandemic influenza in the United States: priorities for intervention.

Authors:  M I Meltzer; N J Cox; K Fukuda
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.